166 related articles for article (PubMed ID: 26491079)
21. Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells.
Tamada M; Suematsu M; Saya H
Clin Cancer Res; 2012 Oct; 18(20):5554-61. PubMed ID: 23071357
[TBL] [Abstract][Full Text] [Related]
22. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
Mazurek S
Int J Biochem Cell Biol; 2011 Jul; 43(7):969-80. PubMed ID: 20156581
[TBL] [Abstract][Full Text] [Related]
23. TEPP-46-Based AIE Fluorescent Probe for Detection and Bioimaging of PKM2 in Living Cells.
Wang D; Li C; Zhu Y; Song Y; Lu S; Sun H; Hao H; Xu X
Anal Chem; 2021 Sep; 93(37):12682-12689. PubMed ID: 34505513
[TBL] [Abstract][Full Text] [Related]
24. Apigenin Restrains Colon Cancer Cell Proliferation via Targeted Blocking of Pyruvate Kinase M2-Dependent Glycolysis.
Shan S; Shi J; Yang P; Jia B; Wu H; Zhang X; Li Z
J Agric Food Chem; 2017 Sep; 65(37):8136-8144. PubMed ID: 28829588
[TBL] [Abstract][Full Text] [Related]
25. Dimethylaminomicheliolide (DMAMCL) Suppresses the Proliferation of Glioblastoma Cells via Targeting Pyruvate Kinase 2 (PKM2) and Rewiring Aerobic Glycolysis.
Guo J; Xue Q; Liu K; Ge W; Liu W; Wang J; Zhang M; Li QY; Cai D; Shan C; Zhang C; Liu X; Li J
Front Oncol; 2019; 9():993. PubMed ID: 31632919
[TBL] [Abstract][Full Text] [Related]
26. Death-associated protein kinase increases glycolytic rate through binding and activation of pyruvate kinase.
Mor I; Carlessi R; Ast T; Feinstein E; Kimchi A
Oncogene; 2012 Feb; 31(6):683-93. PubMed ID: 21725354
[TBL] [Abstract][Full Text] [Related]
27. [Effect of histamine on hexokinase and pyruvate kinase activity and on RNA synthesis in the uterus of ovariectomized rats].
Pankova TG; Igonina TM; Salganik RI
Probl Endokrinol (Mosk); 1974; 20(4):89-93. PubMed ID: 4449806
[No Abstract] [Full Text] [Related]
28. Aberrant overexpression of pyruvate kinase M2 is associated with aggressive tumor features and the BRAF mutation in papillary thyroid cancer.
Feng C; Gao Y; Wang C; Yu X; Zhang W; Guan H; Shan Z; Teng W
J Clin Endocrinol Metab; 2013 Sep; 98(9):E1524-33. PubMed ID: 23846818
[TBL] [Abstract][Full Text] [Related]
29. Mitochondria, hexokinase and pyruvate kinase isozymes in the aerobic glycolysis of tumor cells.
Petrucci D; Cesare P; Colafarina S
Ital J Biochem; 1997 Sep; 46(3):131-41. PubMed ID: 9442422
[TBL] [Abstract][Full Text] [Related]
30. Pyruvate Kinase Inhibits Proliferation during Postnatal Cerebellar Neurogenesis and Suppresses Medulloblastoma Formation.
Tech K; Tikunov AP; Farooq H; Morrissy AS; Meidinger J; Fish T; Green SC; Liu H; Li Y; Mungall AJ; Moore RA; Ma Y; Jones SJM; Marra MA; Vander Heiden MG; Taylor MD; Macdonald JM; Gershon TR
Cancer Res; 2017 Jun; 77(12):3217-3230. PubMed ID: 28515149
[TBL] [Abstract][Full Text] [Related]
31. Pyruvate kinase M2 (PKM-2) expression and prognostic significance in glioblastoma patients.
Yavuz BB; Kilinc F; Kanyilmaz G; Aktan M
J Neurooncol; 2023 Dec; 165(3):527-533. PubMed ID: 38010491
[TBL] [Abstract][Full Text] [Related]
32. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
[TBL] [Abstract][Full Text] [Related]
33. CHIP/Stub1 regulates the Warburg effect by promoting degradation of PKM2 in ovarian carcinoma.
Shang Y; He J; Wang Y; Feng Q; Zhang Y; Guo J; Li J; Li S; Wang Y; Yan G; Ren F; Shi Y; Xu J; Zeps N; Zhai Y; He D; Chang Z
Oncogene; 2017 Jul; 36(29):4191-4200. PubMed ID: 28346425
[TBL] [Abstract][Full Text] [Related]
34. Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas.
de Lucas AG; Schuhmacher AJ; Oteo M; Romero E; Cámara JA; de Martino A; Arroyo AG; Morcillo MÁ; Squatrito M; Martinez-Torrecuadrada JL; Mulero F
PLoS One; 2016; 11(7):e0158634. PubMed ID: 27462980
[TBL] [Abstract][Full Text] [Related]
35. PKM2 and cancer: The function of PKM2 beyond glycolysis.
Dong G; Mao Q; Xia W; Xu Y; Wang J; Xu L; Jiang F
Oncol Lett; 2016 Mar; 11(3):1980-1986. PubMed ID: 26998110
[TBL] [Abstract][Full Text] [Related]
36. Recent Advances on PKM2 Inhibitors and Activators in Cancer Applications.
Chen P; Lou L; Sharma B; Li M; Xie C; Yang F; Wu Y; Xiao Q; Gao L
Curr Med Chem; 2024; 31(20):2955-2973. PubMed ID: 37455458
[TBL] [Abstract][Full Text] [Related]
37. The Role of Pyruvate Kinase M2 in Cancer Metabolism.
Liu VM; Vander Heiden MG
Brain Pathol; 2015 Nov; 25(6):781-3. PubMed ID: 26526946
[TBL] [Abstract][Full Text] [Related]
38. Pyruvate Kinase M2 Promotes the Activation of Dendritic Cells by Enhancing IL-12p35 Expression.
Jin X; Zhang W; Wang Y; Liu J; Hao F; Li Y; Tian M; Shu H; Dong J; Feng Y; Wei M
Cell Rep; 2020 May; 31(8):107690. PubMed ID: 32460017
[TBL] [Abstract][Full Text] [Related]
39. Molecular association of glucose-6-phosphate isomerase and pyruvate kinase M2 with glyceraldehyde-3-phosphate dehydrogenase in cancer cells.
Das MR; Bag AK; Saha S; Ghosh A; Dey SK; Das P; Mandal C; Ray S; Chakrabarti S; Ray M; Jana SS
BMC Cancer; 2016 Feb; 16():152. PubMed ID: 26911935
[TBL] [Abstract][Full Text] [Related]
40. NEK2 Promotes Aerobic Glycolysis in Multiple Myeloma Through Regulating Splicing of Pyruvate Kinase.
Gu Z; Xia J; Xu H; Frech I; Tricot G; Zhan F
J Hematol Oncol; 2017 Jan; 10(1):17. PubMed ID: 28086949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
